Ambu strengthens European presence with Medicotest
This article was originally published in Clinica
Executive Summary
Ambu, which manufactures hospital equipment, is to pay DKr190 million ($24 million) in cash and shares to buy fellow Danish company Medicotest, Europe's leading supplier of disposable electrodes for ECG, neurology and defibrillation applications. Medicotest founder Jan Rasmussen, who holds the absolute majority of shares in the company, will receive DKr117 million in cash. Mr Rasmussen is expected to take a seat on the board.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add a new product – Tibsovo, Servier’s treatment for IDH1-mutated acute myeloid leukemia and IDH1-mutated cholangiocarcinoma.
AstraZeneca’s IBD Hopes Deflated Amid Evolving Market And Pipeline Competition
The major’s attempt to break into Crohn’s disease and ulcerative colitis has been cut short as a highly competitive market and pipeline, intensified by the entrance of biosimilars, renders further development of brazikumab impractical.
Europe's Unitary Patent System Starts Up Today
The forthcoming unitary patent system and Unified Patent Court promise to make applying for patents in Europe and litigating infringements simpler and less costly for applicants.